Agilent Technologies, a publicly-traded company that provides laboratory instruments, software, services, and consumables to customers in the life sciences, diagnostics, and applied chemical markets, agreed to acquire e-MSion, an early-stage company behind the innovative electron capture dissociation (ECD) technology known as the ExD cell. Financial terms were not disclosed. “Joining Agilent will enable seamless integration of innovative e-MSion ExD technology, data analysis, and visualization tools with Agilent’s powerful LC-QTOF instrumentation to more completely analyze macromolecules and to accelerate biopharma therapeutic discovery and development,” Joe Beckman, e-MSion President and CEO.